经皮椎体成形术治疗椎体血管瘤疗效观察

目的:评估使用经皮椎体成形术(Percutaneous vertebroplast PVP)治疗椎体血管瘤的临床疗效。方法:回顾性分析2008~2015年诊断为椎体血管瘤并在我院进行PVP手术的46例患者,至少6个月术后随访,获取相关的临床数据和资料。对患者在术后疼痛等症状改善,肿瘤复发,Macnab疗效和治疗安全性等方面进行分析。结果:所有患者均在术后有了明显的疼痛改善(P0.05),并在6个月内随着时间的推移疼痛评分逐步下降。有2例患者出现术后肿瘤复发,但无明显症状,未给予特殊处理。余未出现明显并发症。患者的术后SF-36生存质量评分均较术前有较大提高(P0.05)。在患者术后6月时,对其Macnab疗效进行分析,其优良率为93.5%。结论:经皮椎体成形术治疗椎体血管瘤可以有效的改善疼痛症状,且相对安全,并能实现微创治疗。

The Clinical Study of Percutaneous Vertebroplasty for Vertebral Hemangioma

Objective:To evaluate the clinical outcomes of percutaneous vertebroplasty (PVP) in treatment of vertebral hemangioma.Methods:The clinical data of 46 patients who were diagnosed as vertebral hemangioma and treated with PVP in our hospital from 2008 to 2015 were retrospectively analyzed. All patients were followed up at least 6 months after the operation. The clinical outcomes, recurrence, curative effect, life quality and safety were evaluated and compared by visual analogue scale (VAS), modified Macnab criteria and SF-36 before and after operation.Results:The results of postoperative VAS score, quality of life were obviously improved compared with preoperative evaluation (P<0.05), and VAS score was gradually decreased with the time after surgery. There were 2 cases recurrence which had no symptom and no treatment. No other complications were detected. According to the modified Macnab criteria, the outcome showed the excellent and good rate was 93.5 %.Conclusion:PVP is a safe, effective and minimally invasive treatment for the vertebral hemangioma, which can obviously relieve the pain symptoms, and significantly improve the lumbar vertebral function and quality of life.